arrow
A

Akira Kitanaka

Kawasaki Medical School
H指数:29
被引数:4,290

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasms

重型再生障碍性贫血与低危伴骨髓增生不良性骨髓增生异常新生物的比较:巨核细胞计数在区分再生障碍性贫血与骨髓增生异常新生物中的关键作用

2025-04-220
OAAI
Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis

原发性血小板增多症后和真性红细胞增多症后骨髓纤维化的真实临床特征

2023-11-101
PRE
Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model
2023-07-197
OAAI
Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma
2023-02-169
OAAI
Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma
2022-03-293
OAAI
Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
2021-07-1314
OAAI
Clinical significance of soluble CADM1 as a novel marker for adult T-cell leukemia/lymphoma
2020-02-136
OAAI
Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis
2019-03-2915
OAAI
A nationwide survey of hypoplastic myelodysplastic syndrome (a multicenter retrospective study)
2017-09-289
OAAI
Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations
2017-03-012
OAAI
Integrated molecular analysis of adult T cell leukemia/lymphoma
2015-10-05624
PREAI
TET2 is essential for survival and hematopoietic stem cell homeostasis

TET2对于生存和造血干细胞稳态至关重要

LEUKEMIA
IF13.4
2012-04-0381
PREAI